1. Home
  2. KVYO vs LGND Comparison

KVYO vs LGND Comparison

Compare KVYO & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$13.16

Market Cap

4.3B

Sector

N/A

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$270.21

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
LGND
Founded
2012
1987
Country
United States
United States
Employees
N/A
68
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.7B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
KVYO
LGND
Price
$13.16
$270.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
7
Target Price
$34.48
$256.29
AVG Volume (30 Days)
5.4M
175.9K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
N/A
EPS
0.03
N/A
Revenue
$1,234,019,000.00
N/A
Revenue This Year
$24.47
$1.25
Revenue Next Year
$19.66
$19.41
P/E Ratio
$448.31
$76.27
Revenue Growth
31.63
N/A
52 Week Low
$13.38
$111.72
52 Week High
$36.76
$267.27

Technical Indicators

Market Signals
Indicator
KVYO
LGND
Relative Strength Index (RSI) 34.72 79.02
Support Level N/A $199.97
Resistance Level $21.74 N/A
Average True Range (ATR) 0.92 7.65
MACD -0.12 2.78
Stochastic Oscillator 1.47 94.27

Price Performance

Historical Comparison
KVYO
LGND

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: